Northwest Biotherapeutics Inc (NWBO):企業の財務・戦略的SWOT分析

◆英語タイトル:Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH62423FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Northwest Biotherapeutics Inc (NWBO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Northwest Biotherapeutics Inc (NW Bio) is a development-stage biotechnology company. It discovers and develops immunotherapy products to treat cancer. The company uses its proprietary technology platform, DCVax to develop therapeutic product candidates. DCVax is a personalized immune therapy and consists of therapeutic vaccine which uses patient’s own dendritic cells as the therapeutic agent. NW Bio’s product lines include DCVax-L, for the treatment of glioblastoma multiforme (GBM), brain cancer; DCVax-Direct, for the treatment of all inoperable solid tumor cancers; and DCVax-Prostate, for the treatment of late stage prostate cancer. NW Bio is headquartered in Bethesda, Maryland, the US.

Northwest Biotherapeutics Inc Key Recent Developments

Mar 16,2021: Northwest Biotherapeutics Announces Development Completed for Initial Production Capacity of Sawston, UK Facility
Jun 08,2020: Northwest Biotherapeutics: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Northwest Biotherapeutics Inc – Key Facts
Northwest Biotherapeutics Inc – Key Employees
Northwest Biotherapeutics Inc – Key Employee Biographies
Northwest Biotherapeutics Inc – Major Products and Services
Northwest Biotherapeutics Inc – History
Northwest Biotherapeutics Inc – Company Statement
Northwest Biotherapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Northwest Biotherapeutics Inc – Business Description
R&D Overview
Northwest Biotherapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Northwest Biotherapeutics Inc – Strengths
Northwest Biotherapeutics Inc – Weaknesses
Northwest Biotherapeutics Inc – Opportunities
Northwest Biotherapeutics Inc – Threats
Northwest Biotherapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Northwest Biotherapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 16, 2021: Northwest Biotherapeutics Announces Development Completed for Initial Production Capacity of Sawston, UK Facility
Jun 08, 2020: Northwest Biotherapeutics: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Northwest Biotherapeutics Inc, Key Facts
Northwest Biotherapeutics Inc, Key Employees
Northwest Biotherapeutics Inc, Key Employee Biographies
Northwest Biotherapeutics Inc, Major Products and Services
Northwest Biotherapeutics Inc, History
Northwest Biotherapeutics Inc, Subsidiaries
Northwest Biotherapeutics Inc, Key Competitors
Northwest Biotherapeutics Inc, Ratios based on current share price
Northwest Biotherapeutics Inc, Annual Ratios
Northwest Biotherapeutics Inc, Annual Ratios (Cont...1)
Northwest Biotherapeutics Inc, Interim Ratios
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Northwest Biotherapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Northwest Biotherapeutics Inc (NWBO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EnerMech Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary EnerMech Ltd (EnerMech) is a provider of oilfield services. The company offers cranes and lifting services, hydraulic products and services, pipeline and umbilicals services, valve services, equipment rental, training services and industrial services. Its pipeline and umbilical services comp …
  • Intec Pharma ltd (NTEC):企業の財務・戦略的SWOT分析
    Summary Intec Pharma Ltd (Intec Pharma) is a biopharmaceutical company that offers delivery solutions for drugs. The company’s pipeline products include drug indications for Parkinson’s disease, insomnia and other diseases. Its proprietary gastro retentive formulation, offers a drug delivery solutio …
  • SMU S.A. (SMU):企業の財務・戦略的SWOT分析
    SMU S.A. (SMU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Virometix AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Virometix AG (Virometix) is a biotechnology company that develops vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. The company’s pipeline products include prophylactic and therapeutic vaccines for infectious, respiratory, and onc …
  • Medline Industries Inc:医療機器:M&Aディール及び事業提携情報
    Summary Medline Industries Inc (Medline) is a manufacturer and distributor of healthcare supplies in the US. The company offers products under various categories, including Exam Gloves, Textiles, Durable Medical Equipment, Skin Care, OR Kits, Protective Apparel, Gauze, Packs and Gowns, Bathing Syste …
  • Serco Group plc (SRP):企業の財務・戦略的SWOT分析
    Serco Group plc (SRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Time Technoplast Ltd:企業の戦略・SWOT・財務情報
    Time Technoplast Ltd - Strategy, SWOT and Corporate Finance Report Summary Time Technoplast Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Fountain Biopharma Inc (4159):製薬・医療:M&Aディール及び事業提携情報
    Summary Fountain Biopharma Inc (Fountain Biopharma), a subsidiary of Microbio Co Ltd, is a developer of therapeutic monoclonal antibodies and DNA aptamers. The company’s technologies include IgE development platform, IEA’s drug development platform and tumor stem cell culture platform. Its IgE devel …
  • ALSO Holding AG:企業の戦略・SWOT・財務情報
    ALSO Holding AG - Strategy, SWOT and Corporate Finance Report Summary ALSO Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Philippine National Bank:企業の戦略・SWOT・財務情報
    Philippine National Bank - Strategy, SWOT and Corporate Finance Report Summary Philippine National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • RXi Pharmaceuticals Corporation:企業のM&A・事業提携・投資動向
    RXi Pharmaceuticals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RXi Pharmaceuticals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Coesia S.p.A.:戦略・SWOT・企業財務分析
    Coesia S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Coesia S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • DBK Pharmaceutical:製薬・医療:M&Aディール及び事業提携情報
    Summary DBK Pharmaceutical (DBK Pharma) is a pharmaceutical company that develops, manufactures and markets pharmaceutical, herbal brands, food supplements, cosmetics and veterinary products. The company’s pharmaceutical products include chitocal capsule, debeskon, rentensar tablets, pressothioval, …
  • Pacific Edge Ltd (PEB):企業の財務・戦略的SWOT分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that develops, discovers, and commercializes diagnostic tests for the early detection and monitoring of cancer. It offers lead products such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It also develops Cxco …
  • Kohl’s Corporation:企業の戦略・SWOT・財務情報
    Kohl's Corporation - Strategy, SWOT and Corporate Finance Report Summary Kohl's Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Merck & Co., Inc.:企業の戦略・SWOT・財務情報
    Merck & Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Merck & Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Biogen Inc (BIIB)-医療機器分野:企業M&A・提携分析
    Summary Biogen Inc (Biogen) is a global biotechnology company that manufactures and markets drugs for the treatment of neurodegenerative diseases and rare and autoimmune disorders. Its marketed products include Avonex (interferon beta-1a), Tysabri (natalizumab), Tecfidera (dimethyl fumarate), Zinbry …
  • Avid Technology Inc (AVID):企業の財務・戦略的SWOT分析
    Avid Technology Inc (AVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • China Evergrande Group:企業のM&A・事業提携・投資動向
    China Evergrande Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Evergrande Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Ruth’s Hospitality Group, Inc.:企業の戦略・SWOT・財務情報
    Ruth's Hospitality Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ruth's Hospitality Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆